73 FR 217 pg. 66276 - Paperwork Reduction Act; Notice of Intent To Collect; Comment Request
Type: NOTICEVolume: 73Number: 217Page: 66276
FR document: [FR Doc. E8-26553 Filed 11-6-08; 8:45 am]
Agency: Office of National Drug Control Policy
Official PDF Version: PDF Version
OFFICE OF NATIONAL DRUG CONTROL POLICY
Paperwork Reduction Act; Notice of Intent To Collect; Comment Request
AGENCY:
Office of National Drug Control Policy (ONDCP).
ACTION:
ONDCP provides opportunity for public comment concerning the collection of information gathered for the purpose of developing and tracking anti-drug advertising for the National Youth Anti-Drug Media Campaign.
SUMMARY:
This action proposes the renewal of three existing data collection instruments used in the production of ONDCP's National Youth Anti-Drug Media Campaign advertising and Media Campaign tracking.
SUPPLEMENTARY INFORMATION:
I. Purpose
The National Youth Anti-Drug Media Campaign is in the process of renewing three data collection instruments. These data collection instruments-pre-production qualitative (or "focus group") testing of creative advertising concepts (OMB 3201-0011), pre-broadcast quantitative (or "copy") testing of developed advertising (OMB 3201-0006) and a tracking study to measure advertising effectiveness (OMB 3201-0010)-are critical to the continuity and improvement of the Media Campaign and are key contributors to the downturn in drug abuse.
Type of Collections: OMB 3201-0011-Qualitative Research-Focus groups; OMB 3201-0006-Copytesting-15-minute mall intercept interviews; OMB 3201-0010-Tracking Study-15-minute mall intercept interviews.
Title of Collection: See above.
Frequency: OMB 3201-0011-Qualitative Research-Quarterly; OMB 3201-0006-Copytesting-Quarterly; OMB 3201-0010-Tracking Study-Weekly.
Affected Public: Teenagers and adult influencers of teenagers.
Estimated Burden: OMB 3201-0011-Qualitative Research-$11,600; OMB 3201-0006-Copytesting-$16,500; OMB 3201-0010-Tracking Study-$21,000.
II. Special Issues for Comment
ONDCP especially invites comments on: (a) Ways to enhance information quality, utility, and clarity of the collection instruments; and (b) ways to ease the burden on respondents, including the use of automated collection techniques or other forms of information technology.
Comments: Address comments within 60 days to Mark Krawczyk, Executive Office of the President, Office of National Drug Control Policy, Washington, DC 20503; by e-mail at MKrawczyk@ondcp.eop.gov ; or, by fax at (202) 395-0858. For further information, contact Mr. Krawczyk at (202) 395-6720.
Signed in Washington, DC, on November 3, 2008.
Daniel R. Petersen,
Assistant General Counsel.
[FR Doc. E8-26553 Filed 11-6-08; 8:45 am]
BILLING CODE 3180-02-P